The role of adjuvant radiotherapy in pathologically lymph node-positive prostate cancer
详细信息 查看全文
- 作者：Naresh Jegadeesh ; Yuan Liu ; Chao Zhang ; Jim Zhong ; Richard J. Cassidy ; Theresa Gillespie ; Omer Kucuk ; Peter Rossi ; Viraj A. Master ; Mehrdad Alemozaffar and Ashesh B. Jani
- 刊名：Cancer
- 出版年：2017
- 出版时间：February 1, 2017
- 年：2017
- 卷：123
- 期：3
- 页码：512-520
- 全文大小：219K
- ISSN：1097-0142
文摘
Postoperative management of prostate cancer with lymph node involvement (LNI) is controversial. Retrospective evidence supports the selective use of radiotherapy (RT) after extended pelvic lymph node dissection. It is unclear whether this is generalizable to practice in the United States, where extended dissection is uncommon. The authors identified patients with LNI who potentially could derive a survival benefit with adjuvant RT plus androgen-deprivation therapy (ADT).